CAFC Affirms PacBio’s Patent Dispute Loss
shot by IP News Shots / 7:29 pm on 12 May, 2021
The US Court of Appeals for the Federal Circuit (CAFC) has affirmed a patent invalidity ruling by the US District Court for the District of Delaware against Pacific Biosciences of California Inc. (PacBio) The lower court had found that the DNA sequencing patents, that PacBio has accused Oxford Nanopore Technologies Inc. of infringing upon, were invalid based on lack of enablement. The CAFC judge agreed with the reasoning provided by the lower court for the invalidity of the two patents.
Read More at: https://www.reuters.com/article/us-ip-pacbio-patents-idUSKBN2CS2TP